Peer-reviewed veterinary case report
Cell-free DNA patterns in dogs with mammary tumors
By Guil-Luna, Silvia et al.·Published in Frontiers in veterinary science·2023·Grupo Nuevas Terapias en cá, Spain·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Analysis of cell-free DNA concentration, fragmentation patterns andgene expression in mammary tumor-bearing dogs: A pilot study.
- Species:
- dog
Plain-English summary
A group of dogs with mammary tumors was studied to see if analyzing their blood could help understand their cancer better. The researchers found that dogs with more aggressive tumors had higher levels of cell-free DNA (cfDNA) in their blood, which could indicate worse disease. They also noted that certain gene expressions were higher in these dogs, suggesting that blood tests might help monitor tumor characteristics. This study shows that blood tests could be a promising tool for veterinarians to assess and manage cancer in dogs.
People also search for: dog mammary tumor treatment · blood test for dog cancer · signs of cancer in dogs
Abstract
INTRODUCTION: Liquid biopsy based on the analysis of circulating cell-free DNA (cfDNA), as well as on detection of point mutations by digital droplet PCR (ddPCR), has revolutionized the research in oncology. In recent years, this technique has been pioneering in veterinary medicine since it is a minimally invasive approach with very promising results for characterization of tumors. METHODS: The aim of this study was, firstly, to analyze the concentration and the fragmentation pattern of cfDNA of dogs with mammary tumors (= 36) and healthy dogs (= 5) and its correlation with clinicopathological data. Secondly, analysis ofgene expression and the point mutation in the codon 245 were performed in cfDNA and in tumor tissues to assess their potential as plasma biomarkers. RESULTS AND DISCUSSION: Our results highlighted that those dogs with worse clinicopathological characteristics (simple or undifferentiated carcinomas, higher histological grade and presence of peritumoral inflammation) shown higher cfDNA concentration and higher concentrations of short-fragments (<190 bp) than healthy dogs. In addition, although no detection of the point mutation in codon 245 ofgene could be detected neither in plasma nor tumor tissue, an increasedexpression was detected in animals with tumors bearing malignant characteristics. Finally, a high concordance withgene expression in plasma and tumor tissue and cfDNA concentration was also found. The results derived from this work confirm the valuable potential of cfDNA and its fragments, as well as the analysis ofexpression in plasma as useful liquid biomarkers for clinical application in veterinary oncology.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/37065257/